STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD

• Main Authors: O. A. Radaeva (Author), L. A. Balykova (Author), K. Ya. Zaslavskaya (Author), A. V. Taganov (Author), P. A. Bely (Author), Yu. A. Kostina (Author), E. V. Negodnova (Author), S. V. Mashnina (Author), D. D. Bessheinov (Author), M. S. Iskandyarova (Author), V. V. Eremeev (Author), N. M. Chumakov (Author)
• Format: Book
• Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The article presents modern scientific data on long-term clinical and pathogenetic effects of the antiviral drug Areplivir (Favipiravir) in patients with metabolic syndrome in the post-COVID period.The aim of the article is to study long-term cytokine-mediated (IL-6/sIL6r and LIF/sLIFr) pathogenetic...